...
首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Neurotherapeutic potential of kolaviron on neurotransmitter dysregulation, excitotoxicity, mitochondrial electron transport chain dysfunction and redox imbalance in 2-VO brain ischemia/reperfusion injury
【24h】

Neurotherapeutic potential of kolaviron on neurotransmitter dysregulation, excitotoxicity, mitochondrial electron transport chain dysfunction and redox imbalance in 2-VO brain ischemia/reperfusion injury

机译:Kolaviron对神经递质的神经治疗潜力,吞咽性毒性,线粒体电子传输链功能障碍和氧化还原性缺乏在2-Vo脑缺血/再灌注损伤中

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study investigated the effects of post-treatment with kolaviron on a 2-Vessel Occlusion (2-VO) model of cerebral ischemia/reperfusion (I/R) injury in rats to ascertain its level of efficacy as a potential therapeutic agent for stroke. Male Wistar rats submitted to 30 min of bilateral common carotid artery occlusion and 24 h of reperfusion were treated with kolaviron (25-100 mg/kg) or 20 mg/kg quercetin immediately after reperfusion and 2 h post reperfusion. At the end of the period of reperfusion, animals were scored for motor and cognitive deficits. Brain relative weight and water content were determined. Cortices, striata and hippocampi were dissected and processed for estimation of markers of oxidative stress, inflammation, neurotransmitter dysregulation and excitotoxicity. In addition, assessment of hippocampal mitochondrial integrity and histopathological examination of the cortical, striatal and hippocampal regions were carried out. There was reversal of 2-VO ischemia/reperfusion (I/R) induced motor and cognitive deficits by kolaviron post-treatment. Post-treatment with kolaviron also attenuated I/R-induced oxidative stress, neuroinflammatory events, excitotoxicity as well as mitochondrial dysfunction in brain tissues. Histopathological findings showed amelioration of I/R-induced neuronal cell damage by kolaviron post-treatment. The results revealed the multi-target neurotherapeutic activity of kolaviron and suggest that it is a promising candidate for drug development against stroke.
机译:本研究研究了在大鼠脑缺血/再灌注(I / R)损伤的2血管闭塞(2-VO)损伤的2血管闭塞(2-VO)模型中的影响,以确定其作为中风潜在治疗剂的疗效水平。在再灌注后立即用KolaviRON(25-100mg / kg)或20mg / kg槲皮素治疗24小时,在再灌注后立即用Kolaviron(25-100mg / kg)或20mg / kg槲皮素治疗雄性Wistar大鼠。在再灌注期结束时,对电动机和认知缺陷进行评分动物。确定脑相对的重量和水含量。解剖和加工皮质,斯特丽塔和海马,用于估计氧化应激,炎症,神经递质诱发剂和兴奋毒性的标志物。此外,对皮质,纹状体和海马区域进行海马线粒体的完整性和组织病理学检查的评估。通过Kolaviron后处理逆转2-Vo缺血/再灌注(I / R)诱导的电动机和认知缺陷。与Kolaviron后处理也减毒I / R诱导的氧化应激,神经炎性事件,兴奋毒性以及脑组织中的线粒体功能障碍。组织病理学发现显示了通过Kolaviron后治疗的I / R诱导的神经元细胞损伤的改善。结果揭示了Kolaviron的多目标神经治疗活动,并表明它是针对中风的吸毒发育的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号